Both in Pharmaceuticals
TuHURA Biosciences vs Pyxis Oncology
Over the past year HURA returned −2.2% and PYXS returned −50.3%; their daily moves had a correlation of 0.05.
HURA −2.2% PYXS −50.3%Growth of $1, one year, split-adjusted
| Metric | HURA | PYXS |
|---|---|---|
| Price | $2.18 | $1.68 |
| Market cap | $138.9M | $140.1M |
| Today | +8.46% | −1.75% |
| 1 month | +3.8% | −42.5% |
| 6 months | −7.2% | −11.6% |
| Year to date | +188.1% | +46.1% |
| 1 year | −3.1% | −51.9% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 12.7× |
| Net cash | -$4.2M | $33.0M |
| Dividend yield | — | — |
| Volatility (60d) | 67.7% | 120.5% |
| Short % of float | 13.7% | 8.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).